Comment on Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. J. Clin. Med. 2023, 12, 2704

Omer F Eker; Sophie Dupuis-Girod; Claire L Shovlin; Edoardo Boccardi

doi:10.3390/jcm12227179

Comment on Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. J. Clin. Med. 2023, 12, 2704

J Clin Med. 2023 Nov 20;12(22):7179. doi: 10.3390/jcm12227179.

Authors

Omer F Eker^{1

2}, Sophie Dupuis-Girod¹, Claire L Shovlin^{3

4}, Edoardo Boccardi⁵

Affiliations

¹ Hospices Civils de Lyon, 69006 Lyon, France.
² CREATIS Laboratory, INSA-Lyon, 69621 Villeurbanne, France.
³ Imperial College London, London W12 0NN, UK.
⁴ Imperial College Healthcare National Health Service Trust, London W12 0HS, UK.
⁵ Department of Neuroradiology, Grande Ospedale Maggiore Niguarda, 20162 Milan, Italy.

Abstract

We read with interest the recent article by Killian et al. regarding the characteristics and treatment of brain vascular malformations (VMs) in children and adults with hereditary hemorrhagic telangiectasia (HHT) [...].

Grants and funding

C.L.S. acknowledges support from the National Institute for Health Research Imperial Biomedical Research Centre.